Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.
- DOI
- 10.1016/j.jcyt.2018.03.032
- Published
- 2018 Jun
- Container
- Cytotherapy
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jcyt.2018.03.032,
title = {Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.},
author = {Vaquero J and Zurita M and Rico MA and Aguayo C and Bonilla C and Marin E and Tapiador N and Sevilla M and Vazquez D and Carballido J and Fernandez C and Rodriguez-Boto G and Ovejero M and Neurological Cell Therapy Group from Puerta de Hierro-Majadahonda Hospital},
year = {2018},
journal = {Cytotherapy},
doi = {10.1016/j.jcyt.2018.03.032},
url = {https://doi.org/10.1016/j.jcyt.2018.03.032}
}RIS
TY - JOUR TI - Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline. AU - Vaquero J AU - Zurita M AU - Rico MA AU - Aguayo C AU - Bonilla C AU - Marin E AU - Tapiador N AU - Sevilla M AU - Vazquez D AU - Carballido J AU - Fernandez C AU - Rodriguez-Boto G AU - Ovejero M AU - Neurological Cell Therapy Group from Puerta de Hierro-Majadahonda Hospital PY - 2018 JO - Cytotherapy DO - 10.1016/j.jcyt.2018.03.032 UR - https://doi.org/10.1016/j.jcyt.2018.03.032 ER -
APA
J, V., M, Z., MA, R., C, A., C, B., E, M., N, T., M, S., D, V., J, C., C, F., G, R., M, O., & Hospital, N. C. T. G. F. P. D. H. (2018). Intrathecal administration of autologous mesenchymal stromal cells for spinal cord injury: Safety and efficacy of the 100/3 guideline.. Cytotherapy. https://doi.org/10.1016/j.jcyt.2018.03.032
Source records
- pubmed · retrieved 2026-09-26T13:48:15.714Z